GlassScriptPhysician profile
Todd D Lythgoe
NPI 1477571065
$1,858.75
in general payments reported to CMS, 2019-2025
26 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $656 · 2022: $399 · 2023: $275 · 2024: $271 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.65 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $596.08 | 2021-2025 | |
| Ucb, INC. | $238.30 | 2021-2025 | Bimzelx |
| Janssen Biotech, INC. | $203.81 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $142.65 | 2021-2023 | Libtayo |
| Novartis Pharmaceuticals Corporation | $109.72 | 2023-2024 | |
| Lilly USA, LLC | $70.00 | 2021-2025 | Jardiance, Zepbound, Mounjaro |
| Galderma Laboratories, L.P. | $61.13 | 2021-2024 | Aklief |
| Janssen Pharmaceuticals, INC | $51.24 | 2023-2025 | Spravato |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.90 | 2021 | |
| Biofrontera INC. | $45.03 | 2021-2022 | |
| Genzyme Corporation | $37.03 | 2021 | |
| Pfizer INC. | $32.26 | 2021 | |
| Genentech USA, INC. | $27.18 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.56 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.44 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Sun Pharmaceutical Industries INC. | $17.95 | 2022 | |
| Exact Sciences Corporation | $17.87 | 2025 | Cologuard Collection Kit |
| Lucid Diagnostics INC. | $16.90 | 2022 | |
| Merck Sharp & Dohme LLC | $15.20 | 2022 | |
| Dynavax Technologies Corporation | $14.52 | 2025 | Heplisav-B |
| Allergan, INC. | $14.51 | 2022 | |
| Glaxosmithkline, LLC. | $13.75 | 2024 | Shingrix, Arexvy |
| Leo Pharma INC. | $13.53 | 2021 | |
| Incyte Corporation | $13.04 | 2022 | |
| Organon LLC | $2.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Lythgoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.